OmniAb, Inc. (OABI)
NASDAQ: OABI · Real-Time Price · USD
1.620
-0.050 (-2.99%)
At close: Mar 25, 2026, 4:00 PM EDT
1.630
+0.010 (0.62%)
After-hours: Mar 25, 2026, 6:03 PM EDT
OmniAb Market Cap
OmniAb has a market cap or net worth of $234.55 million as of March 25, 2026. Its market cap has decreased by -40.36% in one year.
Market Cap
234.55M
Enterprise Value
200.86M
1-Year Change
-40.36%
Ranking
Category
Stock Price
$1.62
Market Cap Chart
Since October 25, 2022, OmniAb's market cap has decreased from $992.92M to $234.55M, a decrease of -76.38%. That is a compound annual growth rate of -34.47%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 24, 2026 | 241.79M | -9.21% |
| Dec 31, 2025 | 266.32M | -37.83% |
| Dec 31, 2024 | 428.38M | -40.30% |
| Dec 29, 2023 | 717.57M | 73.60% |
| Dec 30, 2022 | 413.36M | -58.37% |
| Oct 25, 2022 | 992.92M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ProKidney | 275.37M |
| Silence Therapeutics | 272.78M |
| Polaryx Therapeutics | 261.33M |
| Cellectis | 252.56M |
| Abeona Therapeutics | 252.16M |
| C4 Therapeutics | 249.80M |
| Coherus Oncology | 245.82M |
| Tenax Therapeutics | 245.41M |